These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16007184)

  • 1. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
    Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
    Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
    Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF; Behrend EI; Wilson SM; Denhardt DT
    Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
    Liu YN; Kang BB; Chen JH
    Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
    Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL
    Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
    Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
    Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
    Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Okadaic acid stimulates osteopontin expression through de novo induction of AP-1.
    Kim HJ; Lee MH; Kim HJ; Shin HI; Choi JY; Ryoo HM
    J Cell Biochem; 2002; 87(1):93-102. PubMed ID: 12210726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
    Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
    Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1.
    Murphy BJ; Andrews GK; Bittel D; Discher DJ; McCue J; Green CJ; Yanovsky M; Giaccia A; Sutherland RM; Laderoute KR; Webster KA
    Cancer Res; 1999 Mar; 59(6):1315-22. PubMed ID: 10096565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells.
    Said HM; Katzer A; Flentje M; Vordermark D
    Radiother Oncol; 2005 Aug; 76(2):200-5. PubMed ID: 16024111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
    Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
    Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREB mediates UTP-directed arterial smooth muscle cell migration and expression of the chemotactic protein osteopontin via its interaction with activator protein-1 sites.
    Jalvy S; Renault MA; Lam Shang Leen L; Belloc I; Reynaud A; Gadeau AP; Desgranges C
    Circ Res; 2007 May; 100(9):1292-9. PubMed ID: 17413042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
    Jin H; Valverde P; Chen J
    Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
    Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
    Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.
    Guo X; Zhang YP; Mitchell DA; Denhardt DT; Chambers AF
    Mol Cell Biol; 1995 Jan; 15(1):476-87. PubMed ID: 7799957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.